Skip to Main Content

Paper Details

A potential primary endpoint for clinical trials in glaucoma neuroprotection.
Sci Rep
1
2023
Author NameAffiliation
Jeffrey M LiebmannEdward S. Harkness Eye Institute, Columbia University Irving Medical Center
  • 1 - 1

Datasets

Release 1.2